Table 3.

Lungs and liver congestion indexes of control rats (CTR) and rats with heart failure (MCT) after 14 days of p.o. administration with PTS : HPβCD complex at 25, 50 or 100 mg·kg⁻¹ dose

Groups	Lungs wet weight/dry weight (g)	Lungs wet weight/BW (mg·g−1)	Liver wet weight/dry weight (g)	Liver wet weight/BW (mg·g−1)
CTR0	2.4 ± 0.12	2.97 ± 0.35	2.85 ± 0.04	31.64 ± 2.43
CTR25	2.2 ± 0.13	2.69 ± 0.14	2.86 ± 0.04	31.86 ± 2.43
CTR50	2.43 ± 0.14	3.11 ± 0.41	2.84 ± 0.05	32.89 ± 2.80
CTR100	2.31 ± 0.12	2.31 ± 0.35	2.86 ± 0.04	32.87 ± 2.43
MCT0	2.7 ± 0.10a	4.31 ± 0.27a	2.95 ± 0.03	35.56 ± 1.43
MCT25	2.57 ± 0.10a	4.37 ± 0.26a	2.86 ± 0.03	34.37 ± 1.83
MCT50	2.36 ± 0.11a	3.85 ± 0.27a	2.85 ± 0.03	34.10 ± 1.85
MCT100	2.68 ± 0.10a	3.62 ± 0.29a	2.88 ± 0.04	36.56 ± 1.98

Values are expressed as mean ± SD, n = 8 animals per group. Two‐way ANOVA and Tukey's post hoc tests were performed. BW, body weight.

^a Significantly different compared with CTR group.